t
On 19 July 2023, Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd, announced the installation of its handheld application, IB Nimble™. The Medical College of Wisconsin's Orthopedic Department adopted IB Nimble™ for use in treating bone metastases, which marks its first installation for disease sites other than brain metastases.
| Date | 19 Jul 2023 |
| Time | 07:00:05 |
| Category | Miscellaneous |
| ID | 4209G |
19 July 2023
IQ-AI Ltd
("IQ-AI" or the "Company")
Imaging Biometrics Installs IB Nimble™ For MCW Bone Mets Treatment
Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE: IQAI, OTCQB: IQAIF), today announced that its handheld application, IB Nimble, has been adopted by Orthopedic Department of the Medical College of Wisconsin for use in their treatment of bone metastases. The handheld app provides real-time collaboration amongst multi-disciplinary teams securely and asynchronously.
Designed initially by Dr. Joseph Bovi, MD, Professor of Radiation Oncology and Neurosurgery at MCW, for brain metastases, IB Nimble's base functionality has been enhanced to accommodate any disease or pathology that requires multi-disciplinary input. The clinical benefit of providing optimized treatments faster to patients with brain metastases is now being afforded to patients with bone mets.
"This marks the first installation for use in diseases sites other than brain metastases and demonstrates that IB Nimble is ready for widespread deployment," said Josh McComack, IB's Director of Software Engineering.
--ENDS-
The Directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:
|
IQ-AI Ltd Trevor Brown/Vinod Kaushal/Brett Skelly/Michael Schmainda Tel: 020 7469 0930 |
|
Peterhouse Capital Limited (Financial Adviser and Broker) Lucy Williams/Heena Karani Tel: 020 7220 9797 |
About Imaging Biometrics® LLC: IB is a wholly-owned subsidiary of IQ-AI Limited, (LON: IQAI) (OTCQB: IQAIF), and focuses on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com. Follow IB on Twitter, @IQAI_IB.